BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)

Paul Sperduto; T. Jonathan Yang; Kathryn Beal; Hubert Pan; Paul Brown; Ananta Bangdiwala; Ryan Shanley; Norman Yeh; Laurie E. Gaspar; Steve Braunstein; Penny Sneed; John M. Boyle; John Kirkpatrick; Kimberley Mak; Helen Shih; Alex Engelman; David Roberge; Nils Arvold; Brian Alexander; Mark Awad; Joseph Contessa; Veronica Chiang; John Hardie; Daniel Ma; Emil Lou; William Sperduto; Minesh Mehta

doi:10.1093/neuonc/now212.106

BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)

Paul Sperduto, T. Jonathan Yang, Kathryn Beal, Hubert Pan, Paul Brown, Ananta Bangdiwala, Ryan Shanley, Norman Yeh, Laurie E. Gaspar, Steve Braunstein, Penny Sneed, John M. Boyle, John Kirkpatrick, Kimberley Mak, Helen Shih, Alex Engelman, David Roberge, Nils Arvold, Brian Alexander, Mark AwadJoseph Contessa, Veronica Chiang, John Hardie, Daniel Ma, Emil Lou, William Sperduto, Minesh Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	18
DOIs	https://doi.org/10.1093/neuonc/now212.106
State	Published - Nov 1 2016

Disciplines

Oncology
Pathology
Critical Care

Access to Document

10.1093/neuonc/now212.106License: Unspecified

Cite this

Sperduto, P., Yang, T. J., Beal, K., Pan, H., Brown, P., Bangdiwala, A., Shanley, R., Yeh, N., Gaspar, L. E., Braunstein, S., Sneed, P., Boyle, J. M., Kirkpatrick, J., Mak, K., Shih, H., Engelman, A., Roberge, D., Arvold, N., Alexander, B., ... Mehta, M. (2016). BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA). Neuro-oncology, 18. https://doi.org/10.1093/neuonc/now212.106

Sperduto, P, Yang, TJ, Beal, K, Pan, H, Brown, P, Bangdiwala, A, Shanley, R, Yeh, N, Gaspar, LE, Braunstein, S, Sneed, P, Boyle, JM, Kirkpatrick, J, Mak, K, Shih, H, Engelman, A, Roberge, D, Arvold, N, Alexander, B, Awad, M, Contessa, J, Chiang, V, Hardie, J, Ma, D, Lou, E, Sperduto, W & Mehta, M 2016, 'BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)', Neuro-oncology, vol. 18. https://doi.org/10.1093/neuonc/now212.106

@article{1a69282682084f849e8bf77f939015ff,

title = "BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)",

author = "Paul Sperduto and Yang, {T. Jonathan} and Kathryn Beal and Hubert Pan and Paul Brown and Ananta Bangdiwala and Ryan Shanley and Norman Yeh and Gaspar, {Laurie E.} and Steve Braunstein and Penny Sneed and Boyle, {John M.} and John Kirkpatrick and Kimberley Mak and Helen Shih and Alex Engelman and David Roberge and Nils Arvold and Brian Alexander and Mark Awad and Joseph Contessa and Veronica Chiang and John Hardie and Daniel Ma and Emil Lou and William Sperduto and Minesh Mehta",

note = "PURPOSE:Lung cancer is the leading worldwide cause of cancer and cancer-related mortality. With improving, molecularly-targeted systemic therapies, lung cancer patients are living longer and are at increased risk for brain metastases. Understanding how prognosis varies across this heterogeneous population is essential to individualizing care and designing future clinical trials.",

year = "2016",

month = nov,

day = "1",

doi = "10.1093/neuonc/now212.106",

language = "American English",

volume = "18",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)

AU - Sperduto, Paul

AU - Yang, T. Jonathan

AU - Beal, Kathryn

AU - Pan, Hubert

AU - Brown, Paul

AU - Bangdiwala, Ananta

AU - Shanley, Ryan

AU - Yeh, Norman

AU - Gaspar, Laurie E.

AU - Braunstein, Steve

AU - Sneed, Penny

AU - Boyle, John M.

AU - Kirkpatrick, John

AU - Mak, Kimberley

AU - Shih, Helen

AU - Engelman, Alex

AU - Roberge, David

AU - Arvold, Nils

AU - Alexander, Brian

AU - Awad, Mark

AU - Contessa, Joseph

AU - Chiang, Veronica

AU - Hardie, John

AU - Ma, Daniel

AU - Lou, Emil

AU - Sperduto, William

AU - Mehta, Minesh

N1 - PURPOSE:Lung cancer is the leading worldwide cause of cancer and cancer-related mortality. With improving, molecularly-targeted systemic therapies, lung cancer patients are living longer and are at increased risk for brain metastases. Understanding how prognosis varies across this heterogeneous population is essential to individualizing care and designing future clinical trials.

PY - 2016/11/1

Y1 - 2016/11/1

UR - https://academic.oup.com/neuro-oncology/article/2541999/BMET-06.

U2 - 10.1093/neuonc/now212.106

DO - 10.1093/neuonc/now212.106

M3 - Article

VL - 18

JO - Neuro-oncology

JF - Neuro-oncology

ER -

BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)

Disciplines

Access to Document

Other files and links

Cite this